Inflammatory and Metabolic Biomarkers and Risk of Liver and Biliary Tract Cancer

被引：170

作者：

Aleksandrova, Krasimira ^{[1
]}

Boeing, Heiner ^{[1
]}

Noethlings, Ute ^{[2
,3
]}

Jenab, Mazda ^{[4
]}

Fedirko, Veronika ^{[4
,5
,6
]}

Kaaks, Rudolf ^{[7
]}

Lukanova, Annekatrin ^{[7
,8
]}

Trichopoulou, Antonia ^{[9
,10
]}

Trichopoulos, Dimitrios ^{[10
,11
,12
]}

Boffetta, Paolo ^{[13
]}

Trepo, Elisabeth ^{[14
]}

Westhpal, Sabine ^{[15
]}

Duarte-Salles, Talita ^{[4
]}

Stepien, Magdalena ^{[4
]}

Overvad, Kim ^{[16
]}

Tjonneland, Anne ^{[17
]}

Halkjaer, Jytte ^{[17
]}

Boutron-Ruault, Marie-Christine ^{[18
,19
,20
]}

Dossus, Laure ^{[18
,19
,20
]}

Racine, Antoine ^{[18
,19
,20
]}

Lagiou, Pagona ^{[9
,11
,12
]}

Bamia, Christina ^{[9
,10
]}

Benetou, Vassiliki ^{[9
,10
]}

Agnoli, Claudia ^{[21
]}

Palli, Domenico ^{[22
]}

Panico, Salvatore ^{[23
]}

Tumino, Rosario ^{[24
]}

Vineis, Paolo ^{[25
,26
]}

Bueno-De-Mesquita, Bas ^{[27
,28
]}

Peeters, Petra H. ^{[26
,29
]}

Gram, Inger Torhild ^{[30
]}

Lund, Eiliv ^{[30
]}

Weiderpass, Elisabete ^{[30
,31
,32
,33
]}

Quiros, J. Ramon ^{[34
]}

Agudo, Antonio ^{[35
]}

Sanchez, Maria-Jose ^{[36
,37
]}

Gavrila, Diana ^{[38
,39
]}

Barricarte, Aurelio ^{[37
,39
]}

Dorronsoro, Miren ^{[40
,41
]}

Ohlsson, Bodil ^{[42
]}

Lindkvist, Bjoern ^{[43
]}

Johansson, Anders ^{[44
]}

Sund, Malin ^{[45
]}

Khaw, Kay-Tee ^{[46
]}

Wareham, Nicholas ^{[47
]}

Travis, Ruth C. ^{[48
]}

Riboli, Elio ^{[26
]}

Pischon, Tobias ^{[49
]}

机构：

[1] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, D-14558 Nuthetal, Germany

[2] Univ Kiel, Inst Epidemiol, Kiel, Germany

[3] Univ Bonn, Inst Ernahrung & Lebensmittelwissenschaften, Dept Nutrit & Food Sci, Nutrit Epidemiol Unit, Bonn, Germany

[4] WHO, IARC, Lyon, France

[5] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA

[6] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[7] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

[8] Umea Univ, Dept Med Biosci Pathol, Umea, Sweden

[9] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, WHO Collaborating Ctr Food & Nutr Policies, GR-11527 Athens, Greece

[10] Hellen Hlth Fdn, Athens, Greece

[11] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA

[12] Acad Athens, Bur Epidemiol Res, Athens, Greece

[13] Mt Sinai Hosp, Sch Med, Inst Translat Epidemiol, New York, NY 10029 USA

[14] Ctr Bioloqie Republ, Lyon, France

[15] Otto Von Guericke Univ, Inst Clin Chem, Magdeburg, Germany

[16] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark

[17] Danish Canc Soc Res Ctr, Copenhagen, Denmark

[18] INSERM, Ctr Res Epidemiol & Populat Hlth CESP, U1018, Nutr Hormones & Womens Hlth Team, Villejuif, France

[19] Univ Paris Sud, UMRS 1018, Villejuif, France

[20] Inst Gustave Roussy, Villejuif, France

[21] Fondaz IRCCS Ist Nazl Tumori, Nutrit Epidemiol Unit, Milan, Italy

[22] Canc Res & Prevent Inst ISPO, Mol & Nutrit Epidemiol Unit, Florence, Italy

[23] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy

[24] M P Arezzo Hosp, Canc Registry & Histopathol Unit, Ragusa, Italy

[25] HuGef Fdn, Turin, Italy

[26] Imperial Coll, Div Epidemiol Publ Hlth & Primary Care, London, England

[27] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands

[28] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands

[29] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands

[30] Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway

[31] Canc Registry Norway, Dept Res, Oslo, Norway

[32] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden

[33] Samfundet Folkhalsan, Helsinki, Finland

[34] Publ Hlth Directorate, Asturias, Spain

[35] Catalan Inst Oncol, Canc Epidemiol Res Program, Unit Nutr Environm & Canc, Barcelona, Spain

[36] Andalusian Sch Publ Hlth, Granada, Spain

[37] Consortium Biomed Res Epidemiol & Publ Hlth, CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

[38] Consejeria Sanidad & Polit Social, Dept Epidemiol, Serv Epidemiol, Murcia, Spain

[39] Navarre Publ Hlth Inst, Pamplona, Spain

[40] CIBERESP, Basque Reg Hlth Dept, San Sebastian, Spain

[41] CIBERESP, BioDonostia Res Inst, San Sebastian, Spain

[42] Lund Univ, Skane Univ Hosp, Div Internal Med, Dept Clin Sci, Malmo, Sweden

[43] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden

[44] Umea Univ, Dept Odontol Publ Hlth & Clin Med, Umea, Sweden

[45] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden

[46] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England

[47] Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol, Cambridge, England

[48] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England

[49] Max Delbruck Ctr Mol Med, Mol Epidemiol Grp, Berlin, Germany

来源：

HEPATOLOGY | 2014年 / 60卷 / 03期

基金：

英国医学研究理事会; 英国惠康基金; 欧洲研究理事会;

关键词：

HEPATOCELLULAR-CARCINOMA RISK; INSULIN-RESISTANCE; COLORECTAL-CANCER; ADIPONECTIN; OBESITY; LEPTIN; DISEASE; INTERLEUKIN-6; INJURY; EPIDEMIOLOGY;

D O I：

10.1002/hep.27016

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Obesity and associated metabolic disorders have been implicated in liver carcinogenesis; however, there are little data on the role of obesity-related biomarkers on liver cancer risk. We studied prospectively the association of inflammatory and metabolic biomarkers with risks of hepatocellular carcinoma (HCC), intrahepatic bile duct (IBD), and gallbladder and biliary tract cancers outside of the liver (GBTC) in a nested case-control study within the European Prospective Investigation into Cancer and Nutrition. Over an average of 7.7 years, 296 participants developed HCC (n = 125), GBTC (n = 137), or IBD (n = 34). Using risk-set sampling, controls were selected in a 2: 1 ratio and matched for recruitment center, age, sex, fasting status, and time of blood collection. Baseline serum concentrations of C-reactive protein (CRP), interleukin-6 (IL-6), C-peptide, total high-molecular-weight (HMW) adiponectin, leptin, fetuin-a, and glutamatdehydrogenase (GLDH) were measured, and incidence rate ratios (IRRs) and 95% confidence intervals (CIs) were estimated using conditional logistic regression. After adjustment for lifestyle factors, diabetes, hepatitis infection, and adiposity measures, higher concentrations of CRP, IL-6, C-peptide, and non-HMWadiponectin were associated with higher risk of HCC (IRR per doubling of concentrations = 1.22; 95% CI = 1.02-1.46; P = 0.03; 1.90; 95% CI = 1.30-2.77; P = 0.001; 2.25; 95% CI = 1.43-3.54; P = 0.0005; and 2.09; 95% CI = 1.19-3.67; P = 0.01, respectively). CRP was associated also with risk of GBTC (IRR = 1.22; 95% CI = 1.05-1.42; P = 0.01). GLDH was associated with risks of HCC (IRR = 1.62; 95% CI = 1.25-2.11; P = 0.0003) and IBD (IRR = 10.5; 95% CI = 2.20-50.90; P = 0.003). The continuous net reclassification index was 0.63 for CRP, IL-6, C-peptide, and non-HMW adiponectin and 0.46 for GLDH, indicating good predictive ability of these biomarkers. Conclusion: Elevated levels of biomarkers of inflammation and hyperinsulinemia are associated with a higher risk of HCC, independent of obesity and established liver cancer risk factors.

引用

页码：858 / 871

页数：14

共 62 条

[1] Leptin and Soluble Leptin Receptor in Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition Cohort [J].

Aleksandrova, Krasimira ;

Boeing, Heiner ;

Jenab, Mazda ;

Bueno-de-Mesquita, H. Bas ;

Jansen, Eugene ;

van Duijnhoven, Franzel J. B. ;

Rinaldi, Sabina ;

Fedirko, Veronika ;

Romieu, Isabelle ;

Riboli, Elio ;

Gunter, Marc J. ;

Westphal, Sabine ;

Overvad, Kim ;

Tjonneland, Anne ;

Halkjaer, Jytte ;

Racine, Antoine ;

Boutron-Ruault, Marie-Christine ;

Clavel-Chapelon, Francoise ;

Kaaks, Rudolf ;

Lukanova, Annekatrin ;

Trichopoulou, Antonia ;

Lagiou, Pagona ;

Trichopoulos, Dimitrios ;

Mattiello, Amalia ;

Pala, Valeria ;

Palli, Domenico ;

Tumino, Rosario ;

Vineis, Paolo ;

Buckland, Genevieve ;

Sanchez, Maria-Jose ;

Amiano, Pilar ;

Maria Huerta, Jose ;

Barricarte, Aurelio ;

Menendez, Virginia ;

Peeters, Petra H. ;

Soderberg, Stefan ;

Palmqvist, Richard ;

Allen, Naomi E. ;

Crowe, Francesca L. ;

Khaw, Kay-Tee ;

Wareham, Nickolas ;

Pischon, Tobias .

CANCER RESEARCH, 2012, 72 (20) :5328-5337

[2]

Alison MR, 2011, RECENT RESULTS CANC, V185, P135, DOI 10.1007/978-3-642-03503-6_8

[3]

[Anonymous], BIOMETRICS

[4]

[Anonymous], 1990, INT CLASSIFICATION D, Vtenth

[5] Serum level of adiponectin and the risk of liver cancer development in chronic Hepatitis C patients [J].

Arano, Toru ;

Nakagawa, Hayato ;

Tateishi, Ryosuke ;

Ikeda, Hitoshi ;

Uchino, Koji ;

Enooku, Kenichiro ;

Goto, Eriko ;

Masuzaki, Ryota ;

Asaoka, Yoshinari ;

Kondo, Yuji ;

Goto, Tadashi ;

Shiina, Shuichiro ;

Omata, Masao ;

Yoshida, Haruhiko ;

Koike, Kazuhiko .

INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (09) :2226-2235

[6] Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace [J].

Baffy, Gyoergy ;

Brunt, Elizabeth M. ;

Caldwell, Stephen H. .

JOURNAL OF HEPATOLOGY, 2012, 56 (06) :1384-1391

[7] A Prospective Study of Plasma Adiponectin and Pancreatic Cancer Risk in Five US Cohorts [J].

Bao, Ying ;

Giovannucci, Edward L. ;

Kraft, Peter ;

Stampfer, Meir J. ;

Ogino, Shuji ;

Ma, Jing ;

Buring, Julie E. ;

Sesso, Howard D. ;

Lee, I-Min ;

Gaziano, John Michael ;

Rifai, Nader ;

Pollak, Michael N. ;

Cochrane, Barbara B. ;

Kaklamani, Virginia ;

Lin, Jennifer H. ;

Manson, JoAnn E. ;

Fuchs, Charles S. ;

Wolpin, Brian M. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (02) :95-103

[8] Inflammation and Liver Cancer New Molecular Links [J].

Berasain, C. ;

Castillo, J. ;

Perugorria, M. J. ;

Latasa, M. U. ;

Prieto, J. ;

Avila, M. A. .

STEROID ENZYMES AND CANCER, 2009, 1155 :206-221

[9] A TEST FOR SYMMETRY IN CONTINGENCY TABLES [J].

BOWKER, AH .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1948, 43 (244) :572-574

[10] Adiponectin action from head to toe [J].

Brochu-Gaudreau, Karine ;

Rehfeldt, Charlotte ;

Blouin, Richard ;

Bordignon, V. ;

Murphy, Bruce D. ;

Palin, Marie-France .

ENDOCRINE, 2010, 37 (01) :11-32

← 1 2 3 4 5 6 7 →